A detailed history of Jpmorgan Chase & CO transactions in Passage Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 273 shares of PASG stock, worth $158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
273
Previous 273 -0.0%
Holding current value
$158
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.86 - $1.73 $949 - $1,909
-1,104 Reduced 80.17%
273 $0
Q4 2023

Feb 12, 2024

SELL
$0.6 - $1.01 $4,804 - $8,088
-8,008 Reduced 85.33%
1,377 $1,000
Q3 2023

Nov 14, 2023

BUY
$0.66 - $1.01 $5,356 - $8,197
8,116 Added 639.56%
9,385 $6,000
Q2 2023

Aug 11, 2023

SELL
$0.82 - $1.19 $481,945 - $699,409
-587,739 Reduced 99.78%
1,269 $1,000
Q4 2022

Feb 13, 2023

SELL
$1.06 - $1.48 $2,340 - $3,267
-2,208 Reduced 0.37%
589,008 $813,000
Q3 2022

Nov 14, 2022

SELL
$1.22 - $2.48 $196,899 - $400,254
-161,393 Reduced 21.44%
591,216 $739,000
Q2 2022

Aug 11, 2022

SELL
$1.63 - $3.46 $40,634 - $86,254
-24,929 Reduced 3.21%
752,609 $1.78 Million
Q1 2022

May 11, 2022

BUY
$2.66 - $6.49 $489,650 - $1.19 Million
184,079 Added 31.02%
777,538 $2.41 Million
Q4 2021

Feb 10, 2022

SELL
$6.24 - $10.2 $1.19 Million - $1.95 Million
-191,138 Reduced 24.36%
593,459 $3.77 Million
Q3 2021

Nov 12, 2021

BUY
$9.73 - $15.52 $7.63 Million - $12.2 Million
784,597 New
784,597 $7.82 Million

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $31.6M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.